Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Lafayette › NPI 1699946509
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $12.44M by Medicaid between Jan 2018 and Dec 2024, across 209 billing codes. Its largest line is 80050, General health panel — 12% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
LAFAYETTE, LA 70508
33aNPI1699946509assigned 03/19/2008
33bProvider typeClinical Medical Laboratory
28Total paid$12.44M
24GClaims1,951,294
24DCodes billed209
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Louisiana

Rank by total paid#6 of 66
Median peer was paid$253K
This provider vs. median49×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018191,197$1.16M
2019192,263$1.10M
2020194,932$1.23M
2021421,878$1.70M
2022292,784$2.12M
2023376,402$2.76M
2024incomplete281,838$2.37M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80050 General health panel 12% 75,933 64,596 $1.45M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 9.3% 83,138 68,553 $1.16M
80061 Lipid panel 7.5% 163,424 132,186 $932K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5.5% 23,617 20,112 $680K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.5% 23,600 20,104 $680K
80053 Comprehensive metabolic panel 4.2% 118,126 97,645 $518K
83036 Hemoglobin; glycosylated (A1C) 3.8% 116,312 92,086 $466K
84443 Thyroid stimulating hormone (TSH) 3.1% 65,240 53,014 $388K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.6% 102,966 83,768 $327K
87086 Culture, bacterial; quantitative colony count, urine 2.6% 86,964 70,048 $323K
87536 2.5% 6,803 6,120 $312K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.4% 21,637 18,184 $293K
197 more codes
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2.1% 13,181 $265K
86480 1.9% 8,644 $234K
84439 1.7% 54,768 $209K
80074 1.4% 10,053 $175K
84403 1.2% 12,843 $149K
87186 1.1% 34,684 $136K
86360 1.1% 6,033 $131K
84153 <1% 15,452 $124K
82607 <1% 16,690 $117K
87088 <1% 32,975 $116K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,985 $108K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 1,583 $102K
84481 <1% 13,232 $92K
82670 <1% 7,319 $90K
86803 <1% 11,849 $89K
82728 <1% 15,323 $87K
87070 <1% 18,042 $84K
85027 <1% 28,211 $76K
82746 <1% 9,398 $64K
86696 <1% 5,354 $63K
81001 <1% 42,963 $58K
84436 <1% 21,921 $58K
83001 <1% 6,513 $58K
84402 <1% 4,688 $57K
84144 <1% 5,755 $57K
83550 <1% 15,523 $56K
87081 <1% 14,700 $55K
86592 <1% 26,139 $53K
87077 <1% 13,382 $50K
84702 <1% 8,843 $50K
86376 <1% 6,250 $48K
83970 <1% 3,192 $47K
86038 <1% 7,593 $47K
83540 <1% 19,005 $46K
83002 <1% 4,893 $44K
82550 <1% 15,173 $44K
87522 Neg quan hep c or qual rna <1% 1,801 $43K
82043 <1% 16,617 $41K
84146 <1% 4,705 $41K
86695 <1% 5,266 $40K
86780 <1% 5,397 $38K
84550 <1% 22,696 $38K
82570 <1% 16,405 $34K
80048 Basic metabolic panel (calcium, ionized) <1% 10,574 $34K
82672 <1% 2,441 $31K
86003 <1% 696 $30K
84479 <1% 11,344 $28K
83615 <1% 15,206 $28K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 54 $27K
82565 <1% 16,252 $26K
84480 <1% 4,907 $26K
84100 <1% 17,145 $26K
82784 <1% 2,072 $26K
87340 <1% 4,748 $25K
84450 <1% 14,945 $25K
82248 <1% 16,430 $25K
86140 <1% 10,710 $24K
83655 <1% 3,071 $23K
82310 <1% 13,639 $23K
86769 <1% 623 $22K
83735 <1% 8,864 $22K
84075 <1% 13,269 $22K
87901 <1% 152 $21K
82947 <1% 16,194 $20K
86235 <1% 506 $20K
84520 <1% 15,863 $20K
82040 <1% 13,317 $20K
84295 <1% 13,356 $20K
80081 <1% 507 $19K
86431 <1% 6,794 $19K
84132 <1% 13,176 $19K
80164 <1% 4,433 $19K
82435 <1% 13,412 $19K
82247 <1% 13,881 $18K
87075 <1% 3,959 $18K
87900 <1% 251 $17K
82950 <1% 8,235 $17K
80076 <1% 4,560 $15K
83880 <1% 1,027 $15K
82785 <1% 1,671 $15K
82627 <1% 1,333 $15K
84155 <1% 13,160 $15K
85652 <1% 11,620 $14K
82533 <1% 1,834 $14K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 717 $13K
86361 <1% 1,062 $13K
86677 <1% 1,048 $13K
87427 <1% 2,080 $12K
81003 <1% 11,173 $12K
86706 <1% 2,045 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 254 $11K
83690 <1% 3,263 $11K
87209 <1% 1,267 $11K
83525 <1% 1,804 $11K
82150 <1% 3,152 $10K
87906 <1% 140 $10K
86060 <1% 2,819 $10K
85610 <1% 7,423 $10K
82787 <1% 680 $10K
82951 <1% 1,799 $10K
87046 <1% 2,089 $10K
87045 <1% 2,077 $10K
86800 <1% 949 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 130 $8K
84305 <1% 696 $8K
82652 <1% 891 $7K
84156 <1% 5,648 $7K
82977 <1% 3,048 $7K
83498 <1% 540 $7K
86850 <1% 1,465 $7K
86593 <1% 3,050 $7K
86225 <1% 1,008 $7K
86787 <1% 929 $7K
83721 <1% 1,816 $6K
85730 <1% 3,509 $6K
84460 <1% 4,113 $6K
80177 <1% 1,011 $5K
80051 <1% 2,418 $5K
87177 <1% 1,269 $5K
86708 <1% 819 $5K
86200 <1% 751 $5K
86762 <1% 616 $5K
85045 <1% 2,276 $5K
82140 <1% 685 $4K
36415 Collection of venous blood by venipuncture <1% 24,522 $4K
80178 <1% 1,541 $3K
86702 <1% 548 $3K
84154 <1% 337 $3K
84703 <1% 847 $3K
86160 <1% 465 $3K
82952 <1% 1,742 $3K
87902 <1% 19 $3K
82575 <1% 528 $2K
87324 <1% 434 $2K
84681 <1% 189 $2K
82274 <1% 241 $2K
86665 <1% 122 $2K
80185 <1% 465 $2K
80069 <1% 824 $2K
86900 <1% 1,177 $2K
86901 <1% 1,155 $2K
80197 <1% 420 $2K
86364 <1% 256 $2K
87205 <1% 1,027 $2K
86704 <1% 203 $1K
85060 <1% 626 $1K
87350 <1% 195 $1K
86701 <1% 285 $1K
86777 <1% 160 $1K
84134 <1% 328 $1K
87329 <1% 213 $1K
83020 <1% 167 $1K
86709 <1% 193 $1K
85660 <1% 384 $991.95
86644 <1% 130 $970.47
86664 <1% 113 $932.22
82374 <1% 748 $863.14
82024 <1% 46 $824.26
87210 <1% 363 $798.22
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 16 $622.50
89055 <1% 299 $607.71
86765 <1% 90 $572.46
87535 <1% 26 $565.21
86304 <1% 97 $523.42
83520 <1% 79 $472.64
84466 <1% 86 $460.89
87076 <1% 90 $448.89
86141 <1% 59 $378.57
87521 Neg quan hep c or qual rna <1% 29 $365.06
86308 <1% 134 $355.40
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 22 $351.81
83021 <1% 27 $335.90
84425 <1% 24 $304.19
87040 <1% 47 $285.95
85018 <1% 260 $258.64
82378 <1% 27 $249.70
83704 <1% 14 $230.29
86341 <1% 16 $199.22
83516 <1% 16 $180.29
84270 <1% 13 $176.59
86738 <1% 19 $163.59
80183 <1% 27 $143.75
86663 <1% 14 $120.33
85014 <1% 124 $119.17
81025 <1% 32 $107.82
80184 <1% 27 $107.64
84478 <1% 63 $92.36
80299 <1% 14 $90.11
84165 <1% 31 $88.71
82105 <1% 17 $74.28
80156 <1% 42 $57.60
82465 <1% 56 $56.93
85007 <1% 30 $33.53
36416 <1% 187 $3.75
G0103 Prostate cancer screening; prostate specific antigen test (psa) 0% 2,903 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 0% 509 $0.00
S3600 Stat laboratory request (situations other than s3601) 0% 156 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.